Study of the Immunologic Effects of Echinacea Purpurea in Adults
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Maximal Level of Tumor Necrosis Factor Alpha (pg/ml)
tumor necrosis factor alpha NK cells and evidence of CD25/69 activation
10 days
No
James A Taylor, MD
Principal Investigator
University of Washington
United States: Food and Drug Administration
09A1236
NCT00860795
March 2009
August 2009
Name | Location |
---|---|
Bastyr University | Kenmore, Washington |